Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
作者信息
Wiesner R H, Porayko M K, Wahlstrom H E, Gores G J, Kamath P S, Hay J E, Krom R A
机构信息
Division of Hepatology, Mayo Clinic, Rochester, Minnesota 55905.